Bausch Health Companies
BHC
$0.10 (-1.18%)
1D
1W
3M
1Y
5Y
ALL
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health, gastroenterology (GI), and dermatology, a range of branded, generic and branded generic pharmaceuticals, over the counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries. The Company operates through five segments: Bausch + Lomb, Salix, International, Solta Medical, and Diversified Products. The Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, Consumer, Surgical, and Ophthalmic Pharmaceuticals products. The Salix segment consists of sales in the United States of gastrointestinal (GI) products. The Solta Medical segment consists of global sales of Solta aesthetic medical devices.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 4 days ago • BHC
Bausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale NewsSeeking Alpha • 8 days ago • BHC
Bausch Health Companies: Improving Core Business Cures Its Bankruptcy RumorsZacks Investment Research • 11 days ago • BHC
Why Is Bausch (BHC) Down 11.7% Since Last Earnings Report?Zacks Investment Research • 15 days ago • BHC
Bausch (BHC) Upgraded to Buy: Here's What You Should KnowCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.